Related Experiment Video
Updated: Jun 23, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Management of community-acquired pneumonia in HIV-infected children
1G25 Paediatric HIV/AIDS Service, Groote Schuur Hospital, Observatory, Cape Town, South Africa. diane@kidzpositive.org
Insights
Pneumonia significantly impacts children, especially those with HIV, leading to severe illness and death. Standard treatment guidelines need adaptation for high HIV prevalence areas to improve outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Pneumonia is a leading cause of death in children globally, particularly in low-income, high HIV prevalence countries.
- HIV-infected children face a higher risk of severe pneumonia, broader spectrum of pathogens, and increased mortality.
- Even HIV-exposed but HIV-negative children exhibit elevated risks for severe pneumonia.
Purpose of the Study:
- To highlight the disproportionate burden of pneumonia in HIV-infected children.
- To underscore the limitations of current pneumonia management guidelines in high HIV settings.
- To advocate for adapted strategies and targeted interventions for this vulnerable population.
Main Methods:
- Review of existing literature on childhood pneumonia and HIV co-infection.
- Analysis of etiological spectrum, antimicrobial resistance, and disease severity in HIV-infected children.
- Comparison of outcomes between HIV-infected and uninfected children.
Main Results:
- HIV-infected children experience more severe pneumonia, polymicrobial infections, and higher mortality rates.
- Antimicrobial resistance is more prevalent in pathogens causing pneumonia in HIV-infected children.
- Standard case-management guidelines show high treatment failure and fatality rates in HIV-infected children.
Conclusions:
- Current pneumonia management guidelines require adaptation for high HIV prevalence settings.
- Preventive strategies like chemoprophylaxis and early antiretroviral therapy are crucial for reducing pneumonia burden in HIV-infected children.
- Addressing pneumonia in HIV-infected children necessitates tailored public health interventions and clinical management.
Abstract:
Pneumonia is a major cause of childhood mortality and morbidity worldwide, particularly in low-income countries. Often, these are also the countries most affected by the HIV epidemic. Pneumonia is the leading cause of death in HIV-infected children and a major cause of hospitalization and healthcare utilization. A broader spectrum of organisms, such as Pneumocystis jiroveci and Gram-negative bacteria, cause pneumonia in HIV-infected children compared with uninfected children. Etiologic organisms have higher rates of antimicrobial resistance in HIV-infected children. Polymicrobial disease is more common in HIV-infected children and associated with an exponential increase in mortality rate. HIV-infected children develop more severe pneumonia and have a worse outcome than HIV-uninfected children. HIV-exposed but HIV-negative children are also at higher risk of severe pneumonia and death compared with HIV-unexposed children. Although case-management guidelines for childhood pneumonia have led to an overall decrease in global childhood morbidity and mortality, HIV-infected children continue to have unacceptably high treatment failure and case fatality rates despite adherence to these guidelines. Standard guidelines require adaptation for use in high HIV-prevalence areas. Specific preventive interventions, including chemoprophylaxis for P. jiroveci pneumonia or for TB and early initiation of highly active antiretroviral therapy, may significantly reduce the burden of pneumonia in HIV-infected children.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:27Cryptococcal Meningitis
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion